SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,375,000 | -3.5% | 125,000 | -16.7% | 1.56% | -2.5% |
| Q4 2017 | $2,460,000 | -59.0% | 150,000 | -62.5% | 1.60% | -3.1% |
| Q3 2017 | $6,000,000 | +217.1% | 400,000 | +86.0% | 1.65% | +54.6% |
| Q2 2017 | $1,892,000 | +142.6% | 215,000 | +43.3% | 1.07% | +177.2% |
| Q1 2017 | $780,000 | +7.7% | 150,000 | +20.0% | 0.39% | +30.8% |
| Q2 2016 | $724,000 | +59.5% | 125,000 | +66.7% | 0.30% | +77.7% |
| Q1 2016 | $454,000 | -75.1% | 75,000 | -62.5% | 0.17% | -72.4% |
| Q4 2015 | $1,826,000 | – | 200,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |